Nutex Health, Inc. — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clinigence Holdings, Inc. (CLNH)
CIK: 0001479681
Period of Report: 2021-01-28

Reporting Person: Luqman Elisa V (Director, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-28	Common Stock	A	1500	$1.61	Acquired	12870	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-28	Officer Stock Option (right to buy)	$1.61	A	400000	Acquired	2031-01-28	Common Stock (400000)	Direct

Footnotes

F1: Includes 1,370 shares owned by Spouse

F2: Upon certain milestones